Search | IOVS | ARVO Journals

Showing 1 – 20 of 28

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Treatment of Oxidative Stress in Primary Retinal Cells by Heme-Albumin as a Novel Therapeutic Approach for Age-Related Macular Degeneration

Megan Allyn; Andre F Palmer; Shigeo Tamiya; Katelyn E Swindle-Reilly

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1298.

ARVO Annual Meeting Abstract June 2023

Combined effects of substrate stiffness and growth factors on fibrosis associated changes of Müller glia cells

Shigeo Tamiya; Sebastian Bejarano; Jasmine McMillan

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1589.

ARVO Annual Meeting Abstract June 2023

Effect of N-oleoyl Dopamine on Myofibroblast Trans-differentiaion of Retinal Pigment Epithelial Cells

Zhao-Hui Song; Lucy Sloan; Kyle Funk; Shigeo Tamiya

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2592.

ARVO Annual Meeting Abstract June 2022

Rho effector Arp2/3 is involved in myofibroblast transdifferentiation of retinal pigment epithelial cells

Shigeo Tamiya; Ganapathy Jagatheesan

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3047 – F0418.

ARVO Annual Meeting Abstract June 2021

Rho is involved in regulation of myocardin-related transcription factor and myofibroblast transdifferentiation of RPE cells

Shigeo Tamiya; Ganapathy Jagatheesan; Shunichiro Ueda

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3636.

ARVO Annual Meeting Abstract July 2019

Myocardin-related Transcription Factor signaling is required for Myofibroblast Transdifferentiation of retinal pigment epithelial cells

Shunichiro Ueda; Kevin McDonald; Hiroshi Goto; Shigeo Tamiya

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4409.

ARVO Annual Meeting Abstract July 2019

Prevention of post-traumatic proliferative vitreoretinopathy using sustained release system of dasatinib

Shigeo Tamiya; Shunichiro Ueda; Kevin McDonald; Betty Nunn; Henry J Kaplan; Martin O'Toole

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5814.

ARVO Annual Meeting Abstract June 2017

MCP-1 disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium

Hidetaka Noma; Kevin McDonald; Masahiko Shimura; Shigeo Tamiya

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):598.

ARVO Annual Meeting Abstract June 2017

Production and characterization of a sustained release system of dasatinib to prevent proliferative vitreoretinopathy

Shigeo Tamiya; Rajat Chauhan; Rayeanne Balgemann; Hidetaka Noma; Kevin McDonald; Henry J Kaplan; Martin O'Toole

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4759.

ARVO Annual Meeting Abstract June 2017

The effect of Dasatinib in PVR model

Kazuhiko Umazume; Ryousuke Matsushima; Rintaro Tsukahara; Naoyuki Yamakawa; Shigeo Tamiya; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5975.

ARVO Annual Meeting Abstract September 2016

PYK2 plays a role in matrix contraction by RPE-derived cells

Shigeo Tamiya; Kevin McDonald; Henry J Kaplan

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):246.

ARVO Annual Meeting Abstract September 2016

The role of FAK in fibrotic matrix contraction by dedifferentiated Müller cells

Rintaro Tsukahara; Kazuhiko Umazume; Naoyuki Yamakawa; Takuya Iwasaki; Henry J Kaplan; Hiroshi Goto; Shigeo Tamiya

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4195.

ARVO Annual Meeting Abstract June 2015

Molecular mechanism of dasatinib inhibition of matrix contraction

Rintaro Tsukahara; Kevin McDonald; Hiroshi Goto; Henry J Kaplan; Shigeo Tamiya

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):410.

ARVO Annual Meeting Abstract April 2014

Dasatinib inhibits contraction of Müller and RPE cells on type I collagen gel assay

Rintaro Tsukahara; Kazuhiko Umazume; Kevin McDonald; Hiroshi Goto; Henry J Kaplan; Shigeo Tamiya

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1081.

ARVO Annual Meeting Abstract June 2013

β-catenin signaling in RPE in experimental PVR

Kazuhiko Umazume; LanHsin Liu; Kevin McDonald; Hiroshi Goto; Henry Kaplan; Shigeo Tamiya

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6252.

Retinal Cell Biology February 2013

Inhibition of PVR with a Tyrosine Kinase Inhibitor, Dasatinib, in the Swine

PDF

Kazuhiko Umazume; LanHsin Liu; Patrick A. Scott; Juan P. Fernandez de Castro; Kevin McDonald; Henry J. Kaplan; Shigeo Tamiya
TAGS: dasatinib, protein-tyrosine kinase inhibitor, suidae, retinal pigment cell
Invest. Ophthalmol. Vis. Sci.. 2013; 54(2):1150-1159. https://doi.org/10.1167/iovs.12-10418

Retina July 2012

Proliferative Vitreoretinopathy in the Swine–A New Model

PDF

Kazuhiko Umazume; Yoreh Barak; Kevin McDonald; LanHsin Liu; Henry J. Kaplan; Shigeo Tamiya
TAGS: epiretinal membrane, eye, retinal pigment cell, suidae, vitreoretinopathy, proliferative, retinal detachment, retina, traction retinal detachment, surgical procedures, operative, intravitreal injections
Invest. Ophthalmol. Vis. Sci.. 2012; 53(8):4910-4916. https://doi.org/10.1167/iovs.12-9768

ARVO Annual Meeting Abstract March 2012

Development of a Swine Model of Proliferative Vitreoretinopathy Using RPE Cells

Kazuhiko Umazume; Yoreh Barak; Kevin L. Mcdonald; Lan Hsin Liu; Henry J. Kaplan; Shigeo Tamiya

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):890.

ARVO Annual Meeting Abstract March 2012

Curcumin as Adjunctive Therapy for Proliferative Vitreoretinopathy

Shigeo Tamiya; Yoreh Barak; Kazuhiko Umazume; LanHsin Liu; Kevin L. McDonald; Henry J. Kaplan

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):898.

ARVO Annual Meeting Abstract April 2011

Tyrosine Kinase Inhibitors Prevent Retinal Pigment Epithelial Cell EMT and Growth

Shigeo Tamiya; LanHsin Liu; Henry J. Kaplan

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6593.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Treatment of Oxidative Stress in Primary Retinal Cells by Heme-Albumin as a Novel Therapeutic Approach for Age-Related Macular Degeneration

Combined effects of substrate stiffness and growth factors on fibrosis associated changes of Müller glia cells

Effect of N-oleoyl Dopamine on Myofibroblast Trans-differentiaion of Retinal Pigment Epithelial Cells

Rho effector Arp2/3 is involved in myofibroblast transdifferentiation of retinal pigment epithelial cells

Rho is involved in regulation of myocardin-related transcription factor and myofibroblast transdifferentiation of RPE cells

Myocardin-related Transcription Factor signaling is required for Myofibroblast Transdifferentiation of retinal pigment epithelial cells

Prevention of post-traumatic proliferative vitreoretinopathy using sustained release system of dasatinib

MCP-1 disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium

Production and characterization of a sustained release system of dasatinib to prevent proliferative vitreoretinopathy

The effect of Dasatinib in PVR model

PYK2 plays a role in matrix contraction by RPE-derived cells

The role of FAK in fibrotic matrix contraction by dedifferentiated Müller cells

Molecular mechanism of dasatinib inhibition of matrix contraction

Dasatinib inhibits contraction of Müller and RPE cells on type I collagen gel assay

β-catenin signaling in RPE in experimental PVR

Inhibition of PVR with a Tyrosine Kinase Inhibitor, Dasatinib, in the Swine

Proliferative Vitreoretinopathy in the Swine–A New Model

Development of a Swine Model of Proliferative Vitreoretinopathy Using RPE Cells

Curcumin as Adjunctive Therapy for Proliferative Vitreoretinopathy

Tyrosine Kinase Inhibitors Prevent Retinal Pigment Epithelial Cell EMT and Growth

To View More...

You must be signed into an individual account to use this feature.